Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Human Mutation
|
November 26, 1999
High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer
J O Bay, N Uhrhammer, D Pernin, et al.
Leukemia
|
November 30, 2007
Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia
L Véronèse, O Tournilhac, P Verrelle, et al.
The International Journal of Biological Markers
|
January 14, 2005
Early CYFRA 21-1 variation predicts tumor response to chemotherapy and survival in locally advanced non-small cell lung cancer patients
P Merle, H Janicot, M Filaire, et al.
Radiation Oncology (London, England)
|
December 8, 2017
Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report
J Biau, E Chautard, E De Schlichting, et al.
Leukemia
|
August 11, 2012
Telomeres and chromosomal instability in chronic lymphocytic leukemia
L Véronèse, O Tournilhac, M Callanan, et al.
Radiation Research
|
October 7, 2000
Effects of low-dose neutrons applied at reduced dose rate on human melanoma cells
C Dionet, A Tchirkov, J P Alard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
J Biau, E Thivat, E Chautard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2021
The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches
P Billard, C Guerriau, C Carpentier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]
M Lapeyre, P Henrot, M Alfonsi, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Human Mutation
|
November 26, 1999
High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer
J O Bay, N Uhrhammer, D Pernin, et al.
Leukemia
|
November 30, 2007
Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia
L Véronèse, O Tournilhac, P Verrelle, et al.
The International Journal of Biological Markers
|
January 14, 2005
Early CYFRA 21-1 variation predicts tumor response to chemotherapy and survival in locally advanced non-small cell lung cancer patients
P Merle, H Janicot, M Filaire, et al.
Radiation Oncology (London, England)
|
December 8, 2017
Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report
J Biau, E Chautard, E De Schlichting, et al.
Leukemia
|
August 11, 2012
Telomeres and chromosomal instability in chronic lymphocytic leukemia
L Véronèse, O Tournilhac, M Callanan, et al.
Radiation Research
|
October 7, 2000
Effects of low-dose neutrons applied at reduced dose rate on human melanoma cells
C Dionet, A Tchirkov, J P Alard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
J Biau, E Thivat, E Chautard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2021
The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches
P Billard, C Guerriau, C Carpentier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]
M Lapeyre, P Henrot, M Alfonsi, et al.
Page
of 6